In this episode, Dr. Shaji Kumar from the Mayo Clinic and Dr. Sagar Lonial from Emory University discuss highlights of the key data from ASH 2020 on the treatment of patients with multiple myeloma. Topics include:

Newly diagnosed multiple myeloma
Relapsed/refractory multiple myeloma
Anti-BCMA therapy: CAR T-cells
Anti-BCMA therapy: bispecific antibodies
Anti-BCMA therapy: antibody–drug conjugates
Novel targeted agents for relapsed/refractory multiple myeloma

Presenters:

Shaji K. Kumar, MD
Mark and Judy Mullins Professor of Hematological Malignancies
Chair, Myeloma Amyloidosis Dysproteinemia Group
Consultant, Division of Hematology
Mayo Clinic
Rochester, Minnesota

Sagar Lonial, MD
Professor and Chair
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute of Emory University
Atlanta, Georgia

Link to the CCO website:
http://bit.ly/30EqUn0

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Expert Insights on Highlights From ASH 2020 on Multiple Myeloma